Loading...
Loading...
- CVS Health Corporation CVS shares moved higher in the premarket after the company reported better than expected Q1 earnings.
- Overall revenues increased 3.5% Y/Y to $69.1 billion, driven by growth across all segments. Sales beat a consensus of $68.4 billion.
- Operating income and adjusted operating income increased 3.4% and 2.2%, respectively. The increase in operating income and adjusted operating income was primarily due to growth in the Pharmacy Services and Health Care Benefits segments, partially offset by declines in the Retail/LTC segment.
- Adjusted EPS of $2.04 grew +7% Y/Y and surpassed the consensus of $1.71.
- Guidance: CVS raised its FY21 GAAP diluted EPS guidance range to $6.24 to $6.36 from $6.06 to $6.22 and adjusted EPS guidance range to $7.56 to $7.68 from $7.39 to $7.55.
- It reaffirmed the FY21 operating cash flow outlook of $12.0 billion to $12.5 billion.
- Price Action: CVS shares are up 3.1% at $80.1 in the premarket trading on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in